Synthetic Multiantigen MVA Vaccine COH04S1 Protects Against SARS-CoV-2 in Syrian Hamsters and Non-Human Primates
F. Chiuppesi, V. H. Nguyen, Y. Park, H. Contreras, V. Karpinski, K. Faircloth, J. Nguyen, M. Kha, D. Johnson, J. Martinez, A. Iniguez, Q. Zhou, T. Kaltcheva, P. Frankel, S. Kar, , D. J. Diamond
This paper shows that the synthetic multiantigen MVA vaccine COH04S1 protects against SARS-CoV-2 in Syrian hamsters and non-human primates through various vaccination routes and dose regimens.
npj Vaccines · Jan 21, 2022Peer-reviewedImmunology